Genotypic analysis of the protease and reverse transcriptase of HIV type 1 isolates from recently infected injecting drug users in western China.

The partial pol gene was analyzed to determine circulating HIV-1 subtypes and the prevalence of drug resistance among recently infected injecting drug users in the west of China. Phylogenetic and bootscanning analyses showed that all 25 sequences belonged to CRF07_BC. No major drug resistance mutations were found, while the CRF07_BC sequences harbored a few highly prevalent polymorphic positions in both the protease and reverse transcriptase regions. It is notable that D60E, L63P and I93L substitutions, which were more common in HIV-1 isolates from PI-treated than untreated patients, were present in most of the isolates. Compared with subtype B, the CRF07_BC strains had a decreased genetic barrier for the V106M mutation, which is selected by efavirenz and leads to high-level resistance to all present nonnucleoside RT inhibitors. Further studies are needed to determine the impact of genetic features of CRF07-BC on antitretroviral susceptibility and evolution of drug resistance mutations.

[1]  H. Xing,et al.  Polymorphism of the protease and reverse transcriptase and drug resistance mutation patterns of HIV-1 subtype B prevailing in China. , 2006, Journal of acquired immune deficiency syndromes.

[2]  Klaus Korn,et al.  The Calculated Genetic Barrier for Antiretroviral Drug Resistance Substitutions Is Largely Similar for Different HIV-1 Subtypes , 2006, Journal of acquired immune deficiency syndromes.

[3]  Jennifer Pan,et al.  Current progress of China's free ART program , 2005, Cell Research.

[4]  N. Constantine,et al.  Update on the laboratory diagnosis and monitoring of HIV infection , 2005, Cell Research.

[5]  S. Lai,et al.  Molecular Epidemiology of HIV-1 Subtypes in Southern China , 2005, Journal of acquired immune deficiency syndromes.

[6]  H. Xing,et al.  Simple Subtyping Assay for Human Immunodeficiency Virus Type 1 Subtypes B, C, CRF01-AE, CRF07-BC, and CRF08-BC , 2004, Journal of Clinical Microbiology.

[7]  Liying Ma,et al.  Identification and Distribution of HIV Type 1 Genetic Diversity and Protease Inhibitor Resistance–Associated Mutations in Shanghai, P. R. China , 2003, Journal of acquired immune deficiency syndromes.

[8]  M. Wainberg,et al.  A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors , 2003, AIDS.

[9]  B. Hahn,et al.  Precise mapping of recombination breakpoints suggests a common parent of two BC recombinant HIV type 1 strains circulating in China. , 2002, AIDS research and human retroviruses.

[10]  M. Graf,et al.  Characterization of a Virtually Full-Length Human Immunodeficiency Virus Type 1 Genome of a Prevalent Intersubtype (C/B′) Recombinant Strain in China , 2000, Journal of Virology.

[11]  R. Shafer,et al.  Reproducibility of human immunodeficiency virus type 1 (HIV-1) protease and reverse transcriptase sequencing of plasma samples from heavily treated HIV-1-infected individuals. , 2000, Journal of virological methods.

[12]  Y. Shao.  [Isolation of human immunodeficiency virus (HIV) in epidemic area of HIV infection in Yunnan Province]. , 1991, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.